Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Hers vs Pallas Health

Hers and Pallas Health both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Hers logo

Hers

6.6
★★★☆☆3.3/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit Hers →
VS
Pallas Health logo

Pallas Health

8.0
★★★★☆4/5

Best for: knowing which pharmacy fills the vial: it names Belmar Pharmacy

Visit Pallas Health →

If you are choosing between Hers and Pallas Health, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Pallas Health leads our six-part score, 8.0 to 6.6. One of the two has an FDA warning letter on record, covered below.

Hers vs Pallas Health price

Hers and Pallas Health start at the same figure, $199 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide costs the same at both, $199 a month; tirzepatide costs the same at both, $299 a month.

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Hers prices compounded injections and brand-name pens, while Pallas Health prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, Hers is the only one of the two with a brand-name price.

Where each one treats patients

Hers lists 50 states, and Pallas Health lists 51 states.

They overlap in 50 states. Pallas Health alone covers District of Columbia.

Pricing

Hers

StartingCompounded
$199/mo
semaglutide
StartingBrand-name
$299/mo
tirzepatide

Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)

Pallas Health

Compounded plan, billed $597 every 12 weeks (not monthly)Compounded
$199$139/mo
Save 30% right now
semaglutide

$139 for the first month, then $597 every 12 weeks, which Pallas advertises as a $199/mo average. Same price at every dose. Provider care and check-ins included.

Compounded plan, billed $897 every 12 weeks (not monthly)Compounded
$299$179/mo
Save 40% right now
tirzepatide

$179 for the first month, then $897 every 12 weeks, advertised as a $299/mo average. Same price at every dose.

What each price covers

Both prices cover the medication itself.

Pallas Health's price also covers the clinician visit and shipping, which Hers does not claim.

Hers is silent on shipping and lab work.

Pallas Health is silent on lab work and coaching.

Hers

Covered by the monthly price

Medication

In the price

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Not stated

Coaching

Charged on top

Pallas Health

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Pallas Health scores 8.0 and Hers 6.6 out of 10.

Pallas Health is stronger on value (4.5 vs 3.0), trust & safety (10.0 vs 5.5) and support (7.0 vs 3.0).

Effectiveness, user experience and accessibility are within half a point.

How we score

Hers

6.6/10

Overall

Pallas Health

8.0/10

Value25%

3.0A
vs
B
4.5

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

5.5A
vs
B
10.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

3.0A
vs
B
7.0

FDA warning letters

The FDA sent Hers a warning letter dated September 9, 2025 (letter 716825), and it is still open.

Pallas Health has no FDA warning letter on record with us.

Features & Coverage

FeatureHersPallas Health
Starting Price$199/mo$199/mo
Features2 features✓8 features
States Available50✓51
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted—✓ Yes
FDA Warning Letters1 letter✓None

About Hers

Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.

Read our full Hers review →

About Pallas Health

$199 and $299 a month are the averages on the compounded plans, with messaging, check-ins and provider care folded in, no membership charged on the side, and the figure unchanged at every dose. Mounjaro, Zepbound, Ozempic and Wegovy sell under their brand names next to compounded tirzepatide and semaglutide. Brentmoor, Inc. is the operator. Disclosure is unusually thorough here: NPIs you can verify against two named advising physicians, Lion MD as clinical partner, six pharmacy partners named, and all 50 states plus DC covered.

Read our full Pallas Health review →

Pros & Cons

Hers

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication
  • Serves all 50 states

Watch-outs

  • Not included in the monthly price: clinician visits, coaching
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued Hers a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Pallas Health

What we like

  • Semaglutide costs $199 a month, close to the $185 median for compounded semaglutide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • Names 6 pharmacies that fill its prescriptions, which most sellers do not
  • We found no FDA warning letters issued to Pallas Health

Watch-outs

  • Tirzepatide costs $299 a month, 20% above the $250 median for compounded tirzepatide across the sellers we compare
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Pallas Health

Pallas Health wins this one, 8.0 to 6.6, above all for knowing which pharmacy fills the vial: it names Belmar Pharmacy. Hers fits better if coverage in all 50 states, which most sellers will not confirm is your priority.

Choose Hers if…

You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.

Choose Pallas Health if…

You want knowing which pharmacy fills the vial: it names Belmar Pharmacy and an opening price near $199 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.7

RxSpan MD

Knowing which pharmacy fills the vial: it names Belmar Pharmacy

6.6

Luvo Health

Moving between compounded and brand without changing seller

8.4

Strut Health

Semaglutide at $99/month, 48% below the typical price

Hers vs Pallas Health: FAQ

Neither on the entry price: Hers and Pallas Health both start at about $199 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
Pallas Health: 51 states against 50, with 50 in common.
Both include the medication itself. Only Pallas Health includes the clinician visit and shipping.
Hers has an open FDA warning letter from September 9, 2025. Pallas Health has none.
No. Neither Hers nor Pallas Health pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.